Comparison of efficacy and safety of rosuvastatin 15 mg vs. 10 mg: subanalysis of the ROSU-PATH trial

28 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 2 - Cardiovascular prevention outcomes I Primary cardiovascular prevention: interventions and outcomes ESC Premium Access ESC Congress 2016

About the speaker

Photo

University Medical Centre of Ljubljana, Ljubljana (Slovenia)

19 More presentations in this session

Presentation thumbnail
Doctor D. Huber (Uppsala, SE)
Presentation thumbnail
Doctor T. Sharma (Baltimore, US)
Presentation thumbnail
Doctor C. Badu-Boateng (Reading, GB)
Presentation thumbnail
Ms C. Barboza (Sao Paulo, BR)
Presentation thumbnail
Doctor D. Brie (Timisoara, RO)

The Event

Event poster

ESC Congress 2016

28 August 2016 08:30 CET